Oncidium foundation is a corporate member of the SNMMI Value Initiative
The Oncidium foundation is a corporate member of the Society [...]
Nuclear Medicine and Molecular Imaging Week: October 4-10, 2020
October 4-10 2020 is nuclear medicine and molecular imaging week! [...]
First clinical results for PSMA TAT using Ac-225-PSMA-I&T in advanced mCRPC patients
First clinical results for PSMA targeted alpha therapy using 225Ac-PSMA-I&T [...]
IAEA activities on Cu-67, Re-186, Sc-47 Theranostic radionuclides and Radiopharmaceuticals
International Atomic Energy Agency (IAEA) activities on 67Cu, 186Re, 47Sc [...]
The Role of Ga-68-FAPI PET/CT for Malignancies of the Lower GI Tract
The Role of 68Ga-FAPI PET/CT for Patients with Malignancies of [...]
Cancer awareness month – September, don’t forget to remember
The month of September represents the prostate cancer, thyroid cancer, [...]
First patients dosed in clinical trial of novel lung and ovarian cancer theranostic
Telix Pharmaceuticals Limited announced that the first two patients have [...]
Sirtex Medical and China Grand Pharmaceutical milestone
Sirtex Medical (“Sirtex”) is a leading manufacturer of targeted liver [...]
The Oncidium foundation supports the SVIMS
In India, the Sri Venkateswara Institute of Medical Sciences (SVIMS), [...]
Atomic Nanogenerators in Targeted Alpha Therapy
Atomic in vivo nanogenerators such as actinium-225, thorium-227, and radium-223 [...]